Pharmaceuticals Archives

Amgen (AMGN.Q) gets a new facility to continue doing Gods work against cancer

December 11, 2019

Amgen (AMGN.Q) signed a lease with BioMed Realty for a new 240,000 square foot Leadership in Energy and Environmental Design (LEED) candidate facility in the Gateway of Pacific campus development in south San Francisco earlier this week.

Merck (MRK.NASDAQ), Sanofi (SNY.NASDQ) – is Big Pharma a cancer?

Lukas Kane

December 9, 2019

December 9, 2019 – “Merger Monday” – a couple of Big Pharma companies announced plans to acquire two cancer-focused biotechs – in separate deals worth a combined $5.2 billion.

Karuna Therapeutics (KRTX.Q) is not the biotech play for the faint-hearted

Special Contributor

November 20, 2019

When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia.

Johnson & Johnson (JNJ.NYSE) issues recall for asbestos laden baby powder, and none are surprised

Joseph Morton

October 18, 2019

Johnson & Johnson (JNJ.NYSE) issued a recall for a single lot of its Baby Powder in response to a FDA test that uncovered the presence of sub-trace levels (no greater than 0.00002%) of chrysotile asbestos contamination in samples from a single bottle purchased from an online retailer.

Regeneron Pharmaceuticals’ (REGN.Q) Dupixent one step closer to providing relief to sufferers

Joseph Morton

September 20, 2019

My best friend growing up married a woman with severe rhinosinusitis and nasal polyps. That sounds about as serious as a case of the common cold and a bad headache, but there were many lost nights where my friend and his wife required an ER visit to get her breathing again.

Investing is a trip and we hope you’re along for the ride – Mushroom Madness

Ethan Reyes

September 18, 2019

Cannabis has been good to us here at equity.guru. There are 1,283 pages of cannabis-related content on our site and it’s still growing.

Cambridge House’s XFuture event spearheads brave new world of psychedelic treatments

Ethan Reyes

September 18, 2019

Last minute attendees can register for Cambridge House’s Extraordinary Future event here and use promocode: FUTURE30 for 30% off.

A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?

Ethan Reyes

August 30, 2019

“Cannabis is dead; long live cannabis.” Mushrooms, mark my words..

China raises the specter of evil cannabis to deflect away from its role in opioid crisis

Joseph Morton

August 28, 2019

China has a bug up its ass about U.S. and Canada’s new permissive cannabis laws.

Johnson & Johnson (JNJ.NYSE) is to pay $572 million as finger-pointing gets under way in opioid epidemic

Joseph Morton

August 26, 2019

An Oklahoma district court judge has ordered Johnson & Johnson (JNJ.NYSE) to pay $572 million for its part in the state’s opioid epidemic.

Regen Biopharma (RGBP.OTC) gets 180% bump for cancer-fighting patent

Joseph Morton

August 7, 2019

We all know someone who’s been touched by cancer.

GW Pharma (GWPH.Q) gets recommendation on cannabis-derived epilepsy drug

Ethan Reyes

July 26, 2019

GW Pharmaceuticals (GWPH.Q) has received a recommendation from the European Medicines Agency (EMA) for the authorization of the company’s Epidyolex cannabis oral solution for use in the treatment of seizures.

Explore Our Pages

Pharmaceuticals

Amgen (AMGN.Q) gets a new facility to continue doing Gods work against cancer

Merck (MRK.NASDAQ), Sanofi (SNY.NASDQ) – is Big Pharma a cancer?

Karuna Therapeutics (KRTX.Q) is not the biotech play for the faint-hearted

Johnson & Johnson (JNJ.NYSE) issues recall for asbestos laden baby powder, and none are surprised

Regeneron Pharmaceuticals’ (REGN.Q) Dupixent one step closer to providing relief to sufferers

Investing is a trip and we hope you’re along for the ride – Mushroom Madness

Cambridge House’s XFuture event spearheads brave new world of psychedelic treatments

A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?

China raises the specter of evil cannabis to deflect away from its role in opioid crisis

Johnson & Johnson (JNJ.NYSE) is to pay $572 million as finger-pointing gets under way in opioid epidemic

Regen Biopharma (RGBP.OTC) gets 180% bump for cancer-fighting patent

GW Pharma (GWPH.Q) gets recommendation on cannabis-derived epilepsy drug

MedMen (MMEN.C): cannabis catastrophe – 5 red flags everyone should have seen

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

Why did Canopy (WEED.T) Aurora (ACB.T) and Aphria (APHA.T) gain $10 million per minute today?

The U.S. Fed and market liquidity or welcome to the everything bubble

Silicon Valley virtual assistants are always on and always listening

Defense Metals (DEN.V) tags 4.01% LREO over 58 meters – locked and loaded for 2020

Cancel reply